about
Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It ...
Read More
1.35
-0.08
(-5.59%)
1.9M
XNAS Volume
XNAS 15 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Biomea Fusion Inc is on 19 May 2026 for the purpose of H.C. Wainwright 4th Annual BioConnect Investor Conference
See details
Not Eligible
Expensive Valuation
Technically Neutral
Biomea Fusion Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..